<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02755246</url>
  </required_header>
  <id_info>
    <org_study_id>preSmartAge</org_study_id>
    <nct_id>NCT02755246</nct_id>
  </id_info>
  <brief_title>Polyamine-enriched Diet in Healthy Older Adults With Subjective Cognitive Decline</brief_title>
  <acronym>preSmartAge</acronym>
  <official_title>Effect of Polyamine-enriched Dietary Supplementation on Cognitive Function in Healthy Older Adults With Subjective Cognitive Decline</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Freie Universität Berlin, Institute of Biology/Genetic, Berlin,Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karl-Franzens-Universität Graz, Institute of Molecular Biosciences, Graz, Austria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <brief_summary>
    <textblock>
      The overall objective of this study is to examine the effect of polyamine supplementation on&#xD;
      cognitive performance of individuals with subjective cognitive decline.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Memory abilities are known to decline during aging, a process that is accelerated in&#xD;
      pathological conditions like subjective, mild cognitive impairment (MCI) and Alzheimer's&#xD;
      disease (AD), all of which are a growing public-health concern with devastating effects.&#xD;
      Polyamines supplementation and corresponding up-regulation of autophagy (i.e., cellular&#xD;
      protein degradation pathways) may be a key target of intervention against age-related memory&#xD;
      decline. The study will investigate whether a polyamine-enriched dietary supplementation&#xD;
      (through capsule intake) could provide positive effects on the cognitive function of elderly&#xD;
      individuals (60-80 years old) with subjective cognitive decline.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cognitive Function (from neuropsychological test battery)</measure>
    <time_frame>Prior to intervention (baseline) and after 3 months of intervention</time_frame>
    <description>Comparing changes in cognitive function in subjects with polyamine intake and placebo treatment (pre vs. post intervention)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Laboratory parameters</measure>
    <time_frame>Prior to intervention (baseline) and after 3 months of intervention</time_frame>
    <description>comparing different markers derived from blood plasma like polyamine concentration (spermine, spermidine) and markers of inflammation pre vs. post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular parameters</measure>
    <time_frame>Prior to intervention (baseline) and after 3 months of intervention</time_frame>
    <description>Comparing intima-media-thickness pre vs. post intervention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Subjective Cognitive Decline</condition>
  <arm_group>
    <arm_group_label>Polyamine supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>750 mg polyamine-rich plant extract per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>750 mg potato starch per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Polyamine supplementation</intervention_name>
    <description>3 months of polyamine supplementation (3 capsules/day)</description>
    <arm_group_label>Polyamine supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo supplementation</intervention_name>
    <description>3 months of placebo intake (3 capsules/day)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cognitive healthy subjects with subjective memory decline and self-reported concerns&#xD;
&#xD;
          -  60-80 years old&#xD;
&#xD;
          -  No manifest dementia (DSM-IV criteria)&#xD;
&#xD;
          -  No limitations in activities of daily living&#xD;
&#xD;
          -  Capacity for consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Gluten, histamine or wheat seedling intolerance&#xD;
&#xD;
          -  Severe neurological, internal or psychological diseases&#xD;
&#xD;
          -  Advanced heart or respiratory diseases, severe arteriosclerosis, untreated thyroid&#xD;
             disease or diabetes&#xD;
&#xD;
          -  Malignant tumors, current or past history&#xD;
&#xD;
          -  Brain tumors, stroke&#xD;
&#xD;
          -  Disorders that impair attention&#xD;
&#xD;
          -  Dementia&#xD;
&#xD;
          -  Coagulation disorder, Marcumar or ASS therapy&#xD;
&#xD;
          -  Drug abuse or alcohol dependency&#xD;
&#xD;
          -  Current polyamine substitution&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Agnes Flöel, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://neurocure.de/klinisches-zentrum/forschung-am-ncrc/ncrc-investigator/ehemahlige-ncrc-arbeitsgruppen.html</url>
    <description>working group is related to healthy aging, cognitive impairments in aging and neurological rehabilitation after stroke</description>
  </link>
  <reference>
    <citation>Eisenberg T, Knauer H, Schauer A, Büttner S, Ruckenstuhl C, Carmona-Gutierrez D, Ring J, Schroeder S, Magnes C, Antonacci L, Fussi H, Deszcz L, Hartl R, Schraml E, Criollo A, Megalou E, Weiskopf D, Laun P, Heeren G, Breitenbach M, Grubeck-Loebenstein B, Herker E, Fahrenkrog B, Fröhlich KU, Sinner F, Tavernarakis N, Minois N, Kroemer G, Madeo F. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009 Nov;11(11):1305-14. doi: 10.1038/ncb1975. Epub 2009 Oct 4.</citation>
    <PMID>19801973</PMID>
  </reference>
  <reference>
    <citation>Gupta VK, Scheunemann L, Eisenberg T, Mertel S, Bhukel A, Koemans TS, Kramer JM, Liu KS, Schroeder S, Stunnenberg HG, Sinner F, Magnes C, Pieber TR, Dipt S, Fiala A, Schenck A, Schwaerzel M, Madeo F, Sigrist SJ. Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner. Nat Neurosci. 2013 Oct;16(10):1453-60. doi: 10.1038/nn.3512. Epub 2013 Sep 1.</citation>
    <PMID>23995066</PMID>
  </reference>
  <reference>
    <citation>Ibe S, Kumada K, Yoshida K, Otobe K. Natto (fermented soybean) extract extends the adult lifespan of Caenorhabditis elegans. Biosci Biotechnol Biochem. 2013;77(2):392-4. Epub 2013 Feb 7.</citation>
    <PMID>23391920</PMID>
  </reference>
  <reference>
    <citation>Minois N, Carmona-Gutierrez D, Madeo F. Polyamines in aging and disease. Aging (Albany NY). 2011 Aug;3(8):716-32. Review.</citation>
    <PMID>21869457</PMID>
  </reference>
  <reference>
    <citation>Schaeffer V, Lavenir I, Ozcelik S, Tolnay M, Winkler DT, Goedert M. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain. 2012 Jul;135(Pt 7):2169-77. doi: 10.1093/brain/aws143. Epub 2012 Jun 10.</citation>
    <PMID>22689910</PMID>
  </reference>
  <reference>
    <citation>Soda K, Dobashi Y, Kano Y, Tsujinaka S, Konishi F. Polyamine-rich food decreases age-associated pathology and mortality in aged mice. Exp Gerontol. 2009 Nov;44(11):727-32. doi: 10.1016/j.exger.2009.08.013. Epub 2009 Sep 6.</citation>
    <PMID>19735716</PMID>
  </reference>
  <reference>
    <citation>Soda K, Kano Y, Sakuragi M, Takao K, Lefor A, Konishi F. Long-term oral polyamine intake increases blood polyamine concentrations. J Nutr Sci Vitaminol (Tokyo). 2009 Aug;55(4):361-6.</citation>
    <PMID>19763038</PMID>
  </reference>
  <reference>
    <citation>Tiboldi A, Lentini A, Provenzano B, Tabolacci C, Höger H, Beninati S, Lubec G. Hippocampal polyamine levels and transglutaminase activity are paralleling spatial memory retrieval in the C57BL/6J mouse. Hippocampus. 2012 May;22(5):1068-74. doi: 10.1002/hipo.22016. Epub 2012 Mar 30.</citation>
    <PMID>22467251</PMID>
  </reference>
  <results_reference>
    <citation>Wirth M, Benson G, Schwarz C, Köbe T, Grittner U, Schmitz D, Sigrist SJ, Bohlken J, Stekovic S, Madeo F, Flöel A. The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trial. Cortex. 2018 Dec;109:181-188. doi: 10.1016/j.cortex.2018.09.014. Epub 2018 Oct 4.</citation>
    <PMID>30388439</PMID>
  </results_reference>
  <results_reference>
    <citation>Schwarz C, Stekovic S, Wirth M, Benson G, Royer P, Sigrist SJ, Pieber T, Dammbrueck C, Magnes C, Eisenberg T, Pendl T, Bohlken J, Köbe T, Madeo F, Flöel A. Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline. Aging (Albany NY). 2018 Jan 8;10(1):19-33. doi: 10.18632/aging.101354.</citation>
    <PMID>29315079</PMID>
  </results_reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 5, 2016</study_first_submitted>
  <study_first_submitted_qc>April 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2016</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Claudia Schwarz</investigator_full_name>
    <investigator_title>Postdoctoral Researcher</investigator_title>
  </responsible_party>
  <keyword>subjective cognitive decline</keyword>
  <keyword>dementia</keyword>
  <keyword>lifestyle</keyword>
  <keyword>polyamine</keyword>
  <keyword>memory</keyword>
  <keyword>elderly</keyword>
  <keyword>prevention</keyword>
  <keyword>treatment</keyword>
  <keyword>dietary supplement</keyword>
  <keyword>Polyamine-enriched diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

